Background And Objectives: The Xg blood group is composed of two antigens, Xg (XG1) and CD99 (XG2 and MIC2). The XG and CD99 are homologous genes located on pseudoautosomal region 1 of the X and Y chromosomes. The expressions of Xg and CD99 are co-regulated by a single nucleotide polymorphism (rs311103) in the GATA-1 binding region. Another mechanism of the Xg(a-) phenotype is the genomic deletion of approximately 114 kb, including the XG gene. Anti-Xg seems to be naturally occurring by detection in males who have never been transfused.

Materials And Methods: In this study, we identified 23 anti-Xg producers among 580,115 donors (0.004%). Additional 12 anti-Xg producers were also identified from a separate cohort.

Results: All 35 anti-Xg producers were male. Genomic DNA was obtained from 34 of 35 producers, and all 34 producers were confirmed to carry the XG-gene-deficient allele (XGdel). The breakpoints of all 34 producers were identical. The XGdel was also identified in 12 non-producers of anti-Xg among 860 donors who have no antibodies against RBCs, and the breakpoints were also identical with the anti-Xg producers.

Conclusion: Our results will serve as the basis for a more complete understanding of Xg blood group polymorphisms.

Download full-text PDF

Source
http://dx.doi.org/10.1111/vox.13342DOI Listing

Publication Analysis

Top Keywords

anti-xg producers
16
blood group
8
anti-xg
7
producers
7
genetic background
4
background anti-xg
4
producers japanese
4
japanese blood
4
blood donors
4
donors background
4

Similar Publications

Background And Objectives: The Xg blood group is composed of two antigens, Xg (XG1) and CD99 (XG2 and MIC2). The XG and CD99 are homologous genes located on pseudoautosomal region 1 of the X and Y chromosomes. The expressions of Xg and CD99 are co-regulated by a single nucleotide polymorphism (rs311103) in the GATA-1 binding region.

View Article and Find Full Text PDF

Background: The PBDX/XG gene encoding the Xg blood group antigen was described in 1994, but the genetic determinant of XG expression on RBCs was reported only in 2018. However, the frequencies of Xg(a-) individuals could not explain the rarity of anti-Xg makers. We therefore sought to elucidate the molecular basis of the Xg(a-) phenotype in people producing anti-Xg .

View Article and Find Full Text PDF

Brefeldin A (BFA), a specific inhibitor of Golgi-mediated secretion in animal cells, has been used to study the organization of the secretory pathway and the function of the Golgi apparatus in plant cells. To this end, we have employed a combination of electron microscopical, immunocytochemical, and biochemical techniques to investigate the effects of this drug on the architecture of the Golgi apparatus as well as on the secretion of proteins and complex cell wall polysaccharides in sycamore maple (Acer pseudoplatanus) suspension-cultured cells. We have used 2.

View Article and Find Full Text PDF

The Golgi apparatus of plant cells is the site of assembly of glycoproteins, proteoglycans, and complex polysaccharides, but little is known about how the different assembly pathways are organized within the Golgi stacks. To study these questions we have employed immunocytochemical techniques and antibodies raised against the hydroxyproline-rich cell wall glycoprotein, extensin, and two types of complex polysaccharides, an acidic pectic polysaccharide known as rhamnogalacturonan I (RG-I), and the neutral hemicellulose, xyloglucan (XG). Our micrographs demonstrate that individual Golgi stacks can process simultaneously glycoproteins and complex polysaccharides.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!